Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Fish and Richardson
Daiichi Sankyo
Accenture
Citi
Deloitte
Merck
Colorcon
Chinese Patent Office

Generated: July 19, 2018

DrugPatentWatch Database Preview

Lypressin - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for lypressin and what is the scope of lypressin patent protection?

Lypressin
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for lypressin
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Bulk Api Vendors: 21
Patent Applications: 1,038
DailyMed Link:lypressin at DailyMed
Medical Subject Heading (MeSH) Categories for lypressin
Synonyms for lypressin
(2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5
(2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)1,2-d
(2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2
(8-Lysine)vasopressin
(Lys8)-Vasopressin
[8-Lysine]vasopressin
[Lys8]-Vasopressin
[Lys8]AVP
076L754
1-[[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentaazacycloeicos-4-y
1-[19-amino-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[5-amino-1-[(2-amino-2-oxo-ethyl)carbamoyl]p
1-{[(4R,7S,10S,13S,16S,19R)-19-Amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-L-p rolyl-L-lysylglycinamide
1-{[19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolyllysylglycinamide
1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane-10-propionamide
19-amino-4-[2-[[5-amino-1-[(carbamoylmethyl)carbamoyl]pentyl]carbamoyl]-1-pyrrolidinylcarbonyl]-13-benzyl-7-(carbamoylmethyl)-16-p-hydroxybenzyl-6,9,12,15,18-pentaoxo- (6CI)
3-(Phenylalanine)-8-lysine oxytocin
50-57-7
6-amino-2-({1-[19-amino-13-benzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl]pyrrolidin-2-yl}formamido)-N-(carbamoylmet
7CZF3L922Y
8-L-Lysine vasopressin
8-L-Lysinevasopressin
a-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide
AC1L1L3Q
AC1LD8IK
AC1Q5JBS
AKOS030529559
AM000416
AN-15762
BJFIDCADFRDPIO-DZCXQCEKSA-N
BJFIDCADFRDPIO-UHFFFAOYSA-N
BRD-K93331255-001-01-2
BRN 4648365
C07105
C46H65N13O12S2
CAS-50-57-7
CHEBI:6603
CHEBI:94802
CHEMBL1200690
CHEMBL1991816
CL-017
CS-5838
Cys- Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2
CYS-TYR-PHE-GLN-ASN-CYS-PRO-LYS-GLY-NH2
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 [Disulfide Bridge: 1-6]
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2[Disulfide Bridge: 1-6]
D00366
D09PZZ
Diapid
DIAPID (TN)
DSSTox_CID_28501
DSSTox_GSID_48575
DSSTox_RID_82773
DTXSID8048575
EINECS 200-050-5
FT-0656049
Glycinamide, L-cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysyl-, cyclic (1>6)-disulfide
GTPL2172
HY-P0004
L-Cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysylglycinamide cyclic (1->6)-disulfide
L-Cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysylglycinamide cyclic (1-6)-disulfide
L-lysinamide,
L-Lysine vasopressin
l]carbonyl]-L-prolyl-N-(2-amino-2-oxoethyl)-
Lipresina
Lipresina [INN-Spanish]
Lipressina
Lipressina [DCIT]
LS-161412
LVP
Lypressin (USP/INN)
Lypressin [USAN:INN:BAN]
Lypressin [USAN:USP:INN:BAN]
Lypressine
Lypressine [INN-French]
Lypressinum
Lypressinum [INN-Latin]
Lys-vasopressin
Lysine pitressin
Lysine vasopressin
Lysine-8-vasopressin
Lysine-ADH
Lysine-vasopressin
Lysipressin
Lysipressin acetate
Lysopressin
Lysyl Vasopressin
Lysylvasopressin
MFCD00076754
N-(6-amino-1-((2-amino-2-oxoethyl)amino)-1-oxohexan-2-yl)-1-(19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithi
N-[6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-
NCGC00181743-01
NCGC00181743-02
Oxytocin, 3-(L-phenylalanine)-8-L-lysine-
Postacton
SCHEMBL1650587
SCHEMBL33287
Syntopressin
Tox21_112902
Tox21_113427
UNII-7CZF3L922Y
Vasopressin (lysine form)
Vasopressin-8-lysine
Vasopressin, 8-L-lysine-
Vasopressin, 8-L-lysine- (7CI,8CI,9CI)
Vasopressin, Lysine

US Patents and Regulatory Information for lypressin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis DIAPID lypressin SOLUTION;NASAL 016755-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Department of Justice
Dow
Mallinckrodt
Fish and Richardson
Julphar
Baxter
Accenture
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.